Camp4 Therapeutics (CAMP) Operating Leases (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Operating Leases data on file, last reported at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 63.02% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 63.02% YoY), and the FY2025 full-year result was $1.7 million, down 69.27% from the prior year.
• Operating Leases improved to $1.7 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.5 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• A 4-year average of $4.8 million and a median of $5.1 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases tumbled 35.28% in 2024 and tumbled 69.27% in 2025, its largest moves.
• Tracing CAMP's Operating Leases over 4 years: stood at $8.5 million in 2023, then sank by 35.28% to $5.5 million in 2024, then plunged by 69.27% to $1.7 million in 2025, then gained by 2.96% to $1.7 million in 2026.
• Business Quant data shows CAMP's Operating Leases at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $3.0 million in Q3 2025.